NewAmsterdam Pharma N.V.

NASDAQ: NAMS · Real-Time Price · USD
25.06
-0.11 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
25.07
0.04%
After-hours: Aug 15, 2025, 04:04 PM EDT

NewAmsterdam Pharma Revenue

NewAmsterdam Pharma reported an annual revenue of $45.56M, reflecting a 257% growth. For the quarter ending June 30, 2025, NewAmsterdam Pharma generated $19.14M in revenue.
Revenue (ttm)
45.56M
Revenue Growth
257%
Price / Sales Ratio
53.22
Revenue / Employee
670.04K
Employees
68
Market Cap
2.82B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.